Literature DB >> 15542787

The role of nuclear Y-box binding protein 1 as a global marker in drug resistance.

Michihiko Kuwano1, Yoshinao Oda, Hiroto Izumi, Song-Ju Yang, Takeshi Uchiumi, Yukihide Iwamoto, Masakazu Toi, Teruhiko Fujii, Hideaki Yamana, Hisafumi Kinoshita, Toshiharu Kamura, Masazumi Tsuneyoshi, Kosei Yasumoto, Kimitoshi Kohno.   

Abstract

Gene expression can be regulated by nuclear factors at the transcriptional level. Many such factors regulate MDR1 gene expression, but what are the sequence elements and transcription factors that control the basal and inducible expression of this gene? The general principles through which transcription factors participate in drug resistance are now beginning to be understood. Here, we review the factors involved in the transcriptional regulation of the MDR1 gene. In particular, we focus on the transcription factor Y-box binding protein 1 and discuss the possible links between Y-box binding protein 1 expression and drug resistance in cancer, which are mediated by the transmembrane P-glycoprotein or non-P-glycoprotein.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15542787

Source DB:  PubMed          Journal:  Mol Cancer Ther        ISSN: 1535-7163            Impact factor:   6.261


  41 in total

1.  YB-1 is important for late-stage embryonic development, optimal cellular stress responses, and the prevention of premature senescence.

Authors:  Zhi Hong Lu; Jason T Books; Timothy J Ley
Journal:  Mol Cell Biol       Date:  2005-06       Impact factor: 4.272

2.  Novel Serine 176 Phosphorylation of YBX1 Activates NF-κB in Colon Cancer.

Authors:  Matthew Martin; Laiqing Hua; Benlian Wang; Han Wei; Lakshmi Prabhu; Antja-Voy Hartley; Guanglong Jiang; Yunlong Liu; Tao Lu
Journal:  J Biol Chem       Date:  2017-01-11       Impact factor: 5.157

3.  Interaction network analysis of YBX1 for identification of therapeutic targets in adenocarcinomas.

Authors:  Suriya Narayanan Murugesan; Birendra Singh Yadav; Pramod Kumar Maurya; Amit Chaudhary; Swati Singh; Ashutosh Mani
Journal:  J Biosci       Date:  2019-06       Impact factor: 1.826

4.  YBX1 expression and function in early hematopoiesis and leukemic cells.

Authors:  Jasjeet Bhullar; Vincent E Sollars
Journal:  Immunogenetics       Date:  2011-03-03       Impact factor: 2.846

5.  Proteasome-mediated cleavage of the Y-box-binding protein 1 is linked to DNA-damage stress response.

Authors:  Alexey V Sorokin; Anastasia A Selyutina; Maxim A Skabkin; Sergey G Guryanov; Igor V Nazimov; Christina Richard; John Th'ng; Jonathan Yau; Poul H B Sorensen; Lev P Ovchinnikov; Valentina Evdokimova
Journal:  EMBO J       Date:  2005-09-29       Impact factor: 11.598

6.  Overexpression of Y-box binding protein-1 in cervical cancer and its association with the pathological response rate to chemoradiotherapy.

Authors:  Y Zhang; S R Reng; L Wang; L Lu; Z H Zhao; Z K Zhang; X D Feng; X D Ding; J Wang; G Feng; T Z Dai; J Pu; X B Du
Journal:  Med Oncol       Date:  2011-09-11       Impact factor: 3.064

Review 7.  Clinical Implications of P-Glycoprotein Modulation in Drug-Drug Interactions.

Authors:  Marie Lund; Tonny Studsgaard Petersen; Kim Peder Dalhoff
Journal:  Drugs       Date:  2017-05       Impact factor: 9.546

Review 8.  Disease control by regulation of P-glycoprotein on lymphocytes in patients with rheumatoid arthritis.

Authors:  Shizuyo Tsujimura; Yoshiya Tanaka
Journal:  World J Exp Med       Date:  2015-11-20

9.  Validated prognostic significance of YB-1 genetic variation in metastatic prostate cancer.

Authors:  Masaki Shiota; Shintaro Narita; Tomonori Habuchi; Masatoshi Eto
Journal:  Pharmacogenomics J       Date:  2020-09-22       Impact factor: 3.550

10.  Trilayer micelles for combination delivery of rapamycin and siRNA targeting Y-box binding protein-1 (siYB-1).

Authors:  San Zeng; May P Xiong
Journal:  Biomaterials       Date:  2013-06-12       Impact factor: 12.479

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.